The Latest Cardiac and Vascular News
Funding Will Accelerate Commercialization of the ECGenius™ System and Expand Development of Analytic Modules COPENHAGEN, Denmark, Aug. 17, 2022 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to enhance clinical decision making in the EP lab, today announced the company has secured $7.2 million in funding from existing investors. The financing […]
– Katrin Rupalla, Ph.D., appointed Chair of Ambrx’s Board of Directors – – Ambrx to conduct strategic pipeline review with focus on commercial opportunity and cash runway extension – – Dr. Tian will continue to be available to Ambrx in an advisory capacity – SAN DIEGO–(BUSINESS WIRE)–Ambrx Biopharma Inc., or […]
MOUNTAIN VIEW, Calif., Aug. 16, 2022 /PRNewswire/ — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced its Series F Financing led by GE Healthcare. Also joining the round are NGK-NTK (through a CVC partnership with Pegasus Tech Ventures) and existing investors including Khosla Ventures, Bold Capital Partners, Qualcomm Ventures, […]
NEWTON, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today reported financial results for the second quarter ended June 30, 2022, and provided […]
SANUWAVE Health, Inc. today announced the appointment of Dr. Toni Rinow as CFO Eden Prairie, MN, Aug. 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, today announced the appointment of Dr. Toni Rinow, MBA as Chief Financial Officer (CFO). […]
Westport, CT, Aug. 16, 2022 (GLOBE NEWSWIRE) — Company sees increase in medical centers entering into 60-day evaluation agreements Existing customers seeing positive results from PURE EP™ System expected to increase number of units purchased BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company advancing electrophysiology workflow […]
Eden Prairie, MN, Aug. 15, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, reported financial results for their second quarter ending June 30, 2022, with the SEC on Friday, August 12, 2022. The Company will host a live conference call […]
WALTHAM, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, baxdrostat, for the treatment of hypertension and other cardio-renal diseases, today announced the closing of its previously announced upsized underwritten public offering consisting of an […]
CALGARY, Alberta, Aug. 15, 2022 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix”) (TSX:RVX) today announced the appointment of Dr. Ewelina Kulikowski, Ph.D. as Chief Scientific Officer. Dr. Norman Wong is retiring as CSO, effective today. “Dr. Kulikowski has a contributed tremendously since joining Resverlogix in 2005 and we are delighted to […]
Addition of Experienced Financial Leader Bolsters Strong Management Team SAN JOSE, Calif.–(BUSINESS WIRE)–VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced the appointment of Amy Covert to the position of Chief Financial Officer, effective August 8, 2022. Covert brings more than 20 years of experience to […]
